EyePoint Pharmaceuticals announced the appointment of Jay Duker, M.D. as Chief Executive Officer. Dr. Duker has transitioned from his most recent role as Chief Operating Officer, COO, and President. Dr. Duker has also been appointed to the Board of Directors of the Company, effective today. Nancy Lurker has transitioned to the role of Executive Vice Chair of the Board of Directors from the position of CEO.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on EYPT:
- Analysts Say These 2 Stocks Are Their ‘Top Picks’ for the Rest of 2023
- EyePoint Pharmaceuticals Announces Chief Executive Officer Transition
- Biotech Alert: Searches spiking for these stocks today
- EyePoint named a top pick heading into 2H23 at Cantor Fitzgerald
- EyePoint initiated with a Buy at JonesResearch